JULIE MALLERS: Open Payments
NPI 1396913646 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,235 in 116 payments from 26 companies in 2025. Trend: 2023 $1,756 · 2024 $1,979 · 2025 $2,235
Food & beverage: $2,190Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $406 |
| ABBVIE INC. | 29 | $381 |
| AstraZeneca Pharmaceuticals LP | 7 | $240 |
| Amgen Inc. | 13 | $150 |
| Lilly USA, LLC | 5 | $145 |
| PFIZER INC. | 8 | $143 |
| Phathom Pharmaceuticals, Inc. | 4 | $142 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Almatica Pharma LLC | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
Products named: VRAYLAR, Ozempic, BREZTRI, VOQUEZNA, UBRELVY, Wegovy, OTEZLA, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
